www.fdanews.com/articles/70102-new-england-compounding-center-files-countersuit-against-dusa-pharmaceuticals
New England Compounding Center Files Countersuit Against DUSA Pharmaceuticals
March 21, 2005
New England Compounding Pharmacy Inc. reported that it has filed counterclaims against DUSA Pharmaceuticals Inc. of Wilmington, Mass., alleging, among other things, defamation, violations of the Lanham Act 15 U.S.C.A. Section 1051 et seq., Massachusetts General Laws c. 93A, Section 11, and the tortious interference with advantageous business relationship.